FAvipiravir and HydroxyChloroquine Combination Therapy
NCT04392973
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
268
Enrollment
OTHER
Sponsor class
Conditions
COVID19
Interventions
COMBINATION_PRODUCT:
Favipiravir and Hydroxychloroquine
Sponsor
King Abdullah International Medical Research Center